IRCT20190506043492N4已完成3 期
Investigation of the effect of inhaled heparin in the treatment of patients with adult respiratory distress syndrome hospitalized in the intensive care unit
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Patients 18 to 60 years
- •Under mechanical ventilation for more than 48 hours
- •Respiratory index PAO2 / FIO2 =200 mmhg
- •Bilateral pulmonary infiltration in the chest x-ray
- •Lack of heart disease and previous lung disease
- •Positive end expiratory pressure or PEEP= ventilator 5 cmh2
- •No history of intracerebral hemorrhage in the past 12 months
- •No history of heparin-induced thrombocytopenia
排除标准
- •Dissatisfaction to continue working on the study
- •Hypersensitivity to heparin
- •Uncontrolled bleeding or bleeding disorders
- •PTT and INR impaired
- •Patients receiving therapeutic doses of heparin, anaxaparin and warfarin
研究者
相似试验
已完成
3 期
Evaluation of the effect of nebulized heparin on days without ventilator in intensive care unit patientsAcute respiratory distress syndrom.Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vaporsJ68.3IRCT20211010052718N2Mazandaran University of Medical Sciences74
已完成
2 期
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500
已完成
2 期
Inhaled heparin in pneumoniaVENTILATOR ASSOCIATED PNEUMONIA(VAP).Ventilator associated pneumoniaJ95.851IRCT20140310016917N8Vice chancellor for research of Guilan University of Medical Sciences42
招募中
3 期
Comparison of inhaled heparin/N-acetylcysteine, N-acetylcystein alone, and placepo for the treatment of COVID-19 patientsCOVID-19.Coronavirus infection, unspecifiedB34.2IRCT20201210049672N1Vice-Chancellery for Research Hormozgan University of Medical Sciences25
已完成
不适用
Feasibility and safety of inhaled heparin in intubated and mechanically ventilated patients: a randomised controlled trial comparing three doses of inhaled unfractionated hepariISRCTN28587216Academic Medical Center (AMC) (The Netherlands)24